Vertex Pharma’s Type 1 Diabetes Cell Therapy Shows Potential to Achieve Insulin Independence
Frank Vinluan , 2025-06-23 18:44:00 A Vertex Pharmaceuticals cell therapy for type 1 diabetes is enabling patients to produce insulin, eliminating the need for additional insulin therapy in the vast majority of participants in a key clinical trial. With these preliminary results in hand, the drugmaker is eyeing 2026 regulatory submissions of the therapy, zimislecel….